Continuous Intra-Incisional Bupivacaine for Postoperative Analgesia After Hip Nailing Surgery
Continuous Intra-Incisional Bupivacaine for Postoperative Analgesia After Hip Nailing Surgery
Continuous Intra-Incisional Bupivacaine for Postoperative Analgesia after Hip Nailing Surgery: A Randomized Clinical Trial.
Pain Res Manag . 2024 Jul 22:2024:2357709.Synopsis
Forty-eight patients with intertrochanteric fractures were randomized to receive either continuous intra-incisional bupivacaine infusion (n=24) or no infusion (n=24) following hip nailing surgery. The primary outcome was postoperative pain intensity, measured by the Numerical Rating Scale (NRS). Secondary outcomes included opioid consumption, time to first morphine request, drug-related complicati...
                To view the full content, login to your account,
or start your 30-day FREE Trial today.
            
            FREE TRIAL
            LOGIN
            Forgot Password?
    Explore some of our unlocked ACE Reports below!
 
                Learn about our AI Driven 
 High Impact Search Feature
     
    Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue 
                     
                 
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         LOGIN
                                    LOGIN
                                 
            
Join the Conversation
Please Login or Join to leave comments.